AbCellera
large diversified portfolio in next gen antibody therapies of programs with downstream participation is across the following therapeutic areas ere eel | AbCellera
Company
Deck Type
Sector
Industry
Deck date
May 2022
Slide
22 of 25
Similar slides by AbCellera
See diffirences between slides (animation)
Investor Presentation
July 2022
large diversified portfolio in next gen antibody therapies portfolio of programs with downstream participation is diversified across the following therapeutic areas mana talent | AbCellera
Related slides by other companies
Chimerix
Mergers and Acquisitions
January 2021
acquisition adds portfolio of precision oncology therapies | Chimerix
SoftBank
Results
November 2023
secured a large financial cushion with the completion of program and the growth in mar mar | SoftBank
Tenaya Therapeutics
IPO
July 2021
gene therapy program i i | Tenaya Therapeutics
Other recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io